Nur77: a potential therapeutic target in cancer

nuri77Intracellular infections by Gram-negative bacteria are a snificant global health threat. The nuclear receptor Nur77 (also called TR3, NGFI-B, or NR4A1) was recently shownOrphan nuclear receptor Nur77 has been reported to be implicated in a diverse range of metabolic processes, including carbohydrate metabolism and lipid metabolism.